Sonnet BioTherapeutics
(NASDAQ:SONN)
Sonnet BioTherapeutics Holdings, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Sonnet BioTherapeutics Holdings, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$0.298
0.01[3.47%]
At close: Aug 12
$0.2855
-0.0125[-4.19%]
After Hours: 4:51PM EDT
Day High/Low0.28 - 0.3
52 Week High/Low0.23 - 0.67
Open / Close0.28 / 0.3
Float / Outstanding58.8M / 60.6M
Vol / Avg.313.1K / 1.2M
Mkt Cap18.1M
P/E-
50d Avg. Price0.28
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float58.8M

Sonnet BioTherapeutics (NASDAQ:SONN), Quotes and News Summary

Sonnet BioTherapeutics (NASDAQ: SONN)

Day High/Low0.28 - 0.3
52 Week High/Low0.23 - 0.67
Open / Close0.28 / 0.3
Float / Outstanding58.8M / 60.6M
Vol / Avg.313.1K / 1.2M
Mkt Cap18.1M
P/E-
50d Avg. Price0.28
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float58.8M
Sector: Health Care.Industry: Biotechnology
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Sonnet BioTherapeutics Questions & Answers

Q
How do I buy Sonnet BioTherapeutics (SONN) stock?
A

You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Sonnet BioTherapeutics's (SONN) competitors?
Q
What is the target price for Sonnet BioTherapeutics (SONN) stock?
A

The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting SONN to rise to within 12 months (a possible 1242.28% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Sonnet BioTherapeutics (SONN)?
A

The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $0.298 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Sonnet BioTherapeutics (SONN) pay a dividend?
A

The next Sonnet BioTherapeutics (SONN) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
A

Sonnet BioTherapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Sonnet BioTherapeutics (SONN) going to split?
A

There is no upcoming split for Sonnet BioTherapeutics.

Q
What sector and industry does Sonnet BioTherapeutics (SONN) operate in?
A

Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.